A Science and Technology Blog
“A single dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients. When administered early on during COVID, Virafin will help patients recover faster…
“Both Covishield vaccinated sera and convalescent sera were found to offer protection against the double mutant variant (B.1.617),” says Dr. Rakesh Mishra, Director of CCMB. “This is only a preliminary…
Precious time was wasted before critical facilities began to be scaled up to meet the demands of the second wave that is accelerating at an unprecedented speed leading to healthcare…
In both these cases, the SEC allowed the vaccine manufacturers to use a placebo in the control arm even as two vaccines — Covishield and Covaxin — have been granted…
According to a preliminary report posted on December 19 by the COG-UK Consortium scientists, as of December 15, 1,623 variant genomes have been sequenced. In a December 21 tweet, COG-UK…
Offering the vaccine right away to those in the placebo group will first require unblinding the study. Unblinding the study and offering the vaccine to the placebo group will make it almost impossible to gather further information on vaccine efficacy, thus making full licensure challenging.
The companies have come together under the umbrella of the non-profit Medicines Patent Pool (MPP). Indian companies that have pledged to manufacture COVID-19 drugs include Sun Pharma, Lupin, Aurobindo, Zydus Cadila,…
Even as WHO supported Solidarity Therapeutics Trial found remdesivir to be ineffective in reducing mortality and duration of hospital stay, the global body prequalified the drug the same day the…
